# Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

> **NCT05646303** · PHASE2 · UNKNOWN · sponsor: **Clairvoyant Therapeutics** · enrollment: 128 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05646303
- **Lead sponsor:** Clairvoyant Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-02
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05646303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05646303, "Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05646303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*